Literature DB >> 28639129

The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.

Hideyuki Ogiso1, Hiroyasu Ito2, Ayumu Kanbe1, Tatsuya Ando1, Akira Hara3, Masahito Shimizu4, Hisataka Moriwaki4, Mitsuru Seishima1.   

Abstract

BACKGROUND AND AIM: The inflammatory response accelerates early liver regeneration after liver injury and resection. Recent studies have demonstrated that indoleamine 2,3-dioxygenase-1 (IDO1) suppresses the activation of inflammatory cells and induces immune tolerance. In this study, we examined the role of IDO1 in liver regeneration after partial hepatectomy (PHx).
METHODS: WT or IDO1-knockout (IDO1-KO) mice received 70% PHx. The liver-body weight ratio after PHx was measured and hepatocyte growth was assessed by immunostaining. The expression of cell cycle genes and pro-inflammatory cytokines in the liver was analyzed by quantitative RT-PCR. In addition, 1-methyl-DL-tryptophan (1-MT), which is an IDO1 inhibitory agent, was given to WT mice and the liver-body weight ratio was measured after PHx.
RESULTS: The liver-body weight ratio was significantly increased in IDO1-KO mice compared with that in WT mice after PHx. More Ki-67-positive cells were present in IDO1-KO mice than in WT mice after PHx. The expression of cell cycle genes (cyclin D1, cyclin E) and pro-inflammatory cytokines (IL-1β, TNF-α and IL-6) was up-regulated in the remnant liver of IDO1-KO mice compared with WT mice. Moreover, treatment with 1-MT promoted liver regeneration.
CONCLUSION: IDO1 deficiency promoted early liver regeneration after PHx, indicating that IDO1 suppresses the production of inflammatory cytokines and subsequently inhibits hepatocyte proliferation during liver regeneration.

Entities:  

Keywords:  1-Methyl-DL-tryptophan; Indoleamine 2,3-dioxygenase; Liver regeneration; Partial hepatectomy

Mesh:

Substances:

Year:  2017        PMID: 28639129     DOI: 10.1007/s10620-017-4651-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation.

Authors:  I Kirillova; M Chaisson; N Fausto
Journal:  Cell Growth Differ       Date:  1999-12

3.  NF-kappaB activation in Kupffer cells after partial hepatectomy.

Authors:  Liu Yang; Scott T Magness; Ramon Bataller; Richard A Rippe; David A Brenner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05-19       Impact factor: 4.052

4.  Increased secretion of tumour necrosis factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy.

Authors:  M Iwai; T X Cui; H Kitamura; M Saito; T Shimazu
Journal:  Cytokine       Date:  2001-01-07       Impact factor: 3.861

5.  Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.

Authors:  Hiroyasu Ito; Masato Hoshi; Hirofumi Ohtaki; Ayako Taguchi; Kazuki Ando; Tetsuya Ishikawa; Yosuke Osawa; Akira Hara; Hisataka Moriwaki; Kuniaki Saito; Mitsuru Seishima
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

6.  Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration.

Authors:  Yuichiro Miyaoka; Kazuki Ebato; Hidenori Kato; Satoko Arakawa; Shigeomi Shimizu; Atsushi Miyajima
Journal:  Curr Biol       Date:  2012-05-31       Impact factor: 10.834

7.  Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.

Authors:  Hiroyasu Ito; Tatsuya Ando; Yuko Arioka; Kuniaki Saito; Mitsuru Seishima
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 8.  Tryptophan and the immune response.

Authors:  John R Moffett; Ma Aryan Namboodiri
Journal:  Immunol Cell Biol       Date:  2003-08       Impact factor: 5.126

9.  Immunohistochemistry: paraffin sections using the Vectastain ABC kit from vector labs.

Authors:  Victor Chi; K George Chandy
Journal:  J Vis Exp       Date:  2007-10-01       Impact factor: 1.355

10.  Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy.

Authors:  P Akerman; P Cote; S Q Yang; C McClain; S Nelson; G J Bagby; A M Diehl
Journal:  Am J Physiol       Date:  1992-10
View more
  4 in total

1.  Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features.

Authors:  Mehdi Najar; Emerence Crompot; Gordana Raicevic; Etienne M Sokal; Mustapha Najimi; Laurence Lagneaux
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

2.  Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.

Authors:  Shanshan Jiang; Hui Li; Lianhua Piao; Zheng Jin; Jingyi Liu; Sitong Chen; Luwei Lucy Liu; Yujie Shao; Sheng Zhong; Bo Wu; Weihang Li; Jiaxin Ren; Yu Zhang; Hao Wang; Rihua Jin
Journal:  Aging (Albany NY)       Date:  2020-06-22       Impact factor: 5.682

3.  Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.

Authors:  Shaolong Li; Xue Han; Ning Lyu; Qiankun Xie; Haijing Deng; Luwen Mu; Tao Pan; Xin Huang; Xia Wang; Yuanyuan Shi; Ming Zhao
Journal:  Cancer Sci       Date:  2018-11-05       Impact factor: 6.716

4.  Brassinin Inhibits Proliferation in Human Liver Cancer Cells via Mitochondrial Dysfunction.

Authors:  Taeyeon Hong; Jiyeon Ham; Jisoo Song; Gwonhwa Song; Whasun Lim
Journal:  Cells       Date:  2021-02-05       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.